MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63.
Gamble LD; Kees UR; Tweddle DA; Lunec J; Oncogene, 2012, vol. 31, issue 6, p 752, ISSN 14765594. ISBN 14765594.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef